Rosuvastatin efficacy and safety evaluation in hypercholesterolaemic patients - RESEARCH
Study identifier:NIS-CGR-CRE-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A multi-centre, open label, non-randomised, non interventional, 24 weeks study for the efficacy and safety of rosuvastatin following its administration in real life clinical practice in Greek hypercholesterolaemic patients
Medical condition
hypercholesterolaemia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
810
Study type
Observational
Age
18 Years - 80 Years
Date
Study Start Date: 01 Dec 2007
Primary Completion Date: -
Study Completion Date: 01 Dec 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
